RG
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats | Molecular Pharmaceutics | 2020 | 258 | 2 | |||
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 263 | 2 | |||
Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery | Otology & Neurotology | 2019 | 333 | 0 | |||
Effect of implantation site on outcome of tissue-engineered vascular grafts | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 372 | 1 | |||
A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy | International journal of pharmaceutics | 2015 | 776 | 2 | |||
Controlled drug release from melt-extrudates through processing parameters: A chemometric approach | International journal of pharmaceutics | 2015 | 592 | 0 | |||
Strategies for formulating and delivering poorly water-soluble drugs | Journal of drug delivery science and technology | 2015 | 748 | 1 | |||
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance | European journal of pharmaceutics and biopharmaceutics | 2015 | 647 | 1 | |||
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications | Journal of chromatography | 2013 | 591 | 5 | |||
Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications | European journal of pharmaceutics and biopharmaceutics | 2013 | 627 | 2 | |||
In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application | Journal of controlled release | 2013 | 575 | 0 | |||
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer | Journal of controlled release | 2013 | 594 | 1 | |||
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease | European journal of pharmaceutics and biopharmaceutics | 2012 | 632 | 0 | |||
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives | Carbohydrate Polymers | 2012 | 410 | 0 | |||
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model | Biomaterials | 2012 | 710 | 0 | |||
Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration | Acta biomaterialia | 2012 | 624 | 0 | |||
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect | Journal of biomedical materials research. Part A | 2011 | 673 | 0 | |||
Novel micelle formulations to increase cutaneous bioavailability of azole antifungals | Journal of controlled release | 2011 | 578 | 3 | |||
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation | Journal of controlled release | 2010 | 605 | 0 | |||
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice | Journal of controlled release | 2010 | 619 | 3 | |||
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity | International Journal of Pharmaceutics | 2010 | 357 | 1 | |||
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) | International journal of pharmaceutics | 2010 | 628 | 0 | |||
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? | Circulation | 2009 | 584 | 1 | |||
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye | Investigative ophthalmology & visual science | 2009 | 516 | 0 | |||
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis | Journal of controlled release | 2009 | 647 | 0 | |||
Novel thermosensitive chitosan hydrogels: in vivo evaluation | Journal of biomedical materials research. Part A | 2009 | 647 | 3 | |||
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer | Journal of Drug Targeting | 2009 | 396 | 0 | |||
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems | Journal of controlled release | 2009 | 579 | 0 | |||
A high throughput protein formulation platform: case study of salmon calcitonin | Pharmaceutical research | 2009 | 602 | 395 | |||
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular grafts | Journal of biomedical materials research. Part A | 2009 | 534 | 0 | |||
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases | European journal of pharmaceutics and biopharmaceutics | 2009 | 613 | 0 | |||
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size | European journal of pharmaceutical sciences | 2009 | 609 | 0 | |||
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model | Nanomedicine | 2009 | 597 | 0 | |||
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity | Journal of Drug Targeting | 2009 | 357 | 1 | |||
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells | European journal of pharmaceutical sciences | 2009 | 545 | 0 | |||
A novel thermoresponsive hydrogel based on chitosan | European journal of pharmaceutics and biopharmaceutics | 2008 | 701 | 1 | |||
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound | Drug development and industrial pharmacy | 2008 | 547 | 0 | |||
High throughput methods to characterize protein permeation and release | International journal of pharmaceutics | 2008 | 797 | 3 | |||
Colloidal Drug Delivery Systems - Recent Advances With Polymeric Micelles | Chimia | 2008 | 876 | 38 | |||
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 444 | 1 | |||
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcome | European journal of pharmaceutics and biopharmaceutics | 2008 | 621 | 1 | |||
A biodegradable drug delivery system for the treatment of postoperative inflammation | International journal of pharmaceutics | 2008 | 462 | 1 | |||
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma | Investigative ophthalmology & visual science | 2008 | 622 | 0 | |||
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivatives | Antimicrobial agents and chemotherapy | 2008 | 669 | 0 | |||
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix | Journal of pharmaceutical sciences | 2008 | 606 | 0 | |||
Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA : PEO Diblock and Triblock Copolymers | Journal of drug targeting | 2008 | 17 | 0 | |||
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation | Circulation | 2008 | 531 | 0 | |||
Nanoparticles for drug delivery : the need for precision in reporting particle size parameters | European journal of pharmaceutics and biopharmaceutics | 2008 | 594 | 2 | |||
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles | International journal of pharmaceutics | 2007 | 576 | 0 | |||
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation | International journal of pharmaceutics | 2007 | 637 | 7 | |||
Biological conversion of a water-soluble prodrug of cyclosporine A | European journal of pharmaceutics and biopharmaceutics | 2007 | 553 | 8 | |||
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes | Bioconjugate chemistry | 2007 | 606 | 0 | |||
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems | Journal of biomedical materials research. Part A | 2007 | 614 | 2 | |||
Polymeric photosensitizer prodrugs for photodynamic therapy | Photochemistry and photobiology | 2007 | 580 | 0 | |||
NIR analysis of cellulose and lactose—Application to ecstasy tablet analysis | Forensic science international | 2007 | 887 | 1 | |||
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems | Advanced drug delivery reviews | 2007 | 616 | 2 | |||
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration | Investigative ophthalmology & visual science | 2007 | 498 | 0 | |||
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus | Journal of controlled release | 2007 | 623 | 0 | |||
Characterization of protein aggregation: the case of a therapeutic immunoglobulin | Biochimica et biophysica acta | 2007 | 603 | 0 | |||
Detection and characterization of protein aggregates by fluorescence microscopy | International journal of pharmaceutics | 2007 | 585 | 0 | |||
High throughput screening of protein formulation stability: practical considerations | European journal of pharmaceutics and biopharmaceutics | 2007 | 602 | 0 | |||
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats | Molecular vision | 2006 | 36 | 5 | |||
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating | AAPS PharmSciTech | 2006 | 532 | 160 | |||
Biodegradable nanoparticles for direct or two-step tumor immunotargeting | Bioconjugate chemistry | 2006 | 462 | 0 | |||
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures | Biomaterials | 2006 | 464 | 1 | |||
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer | International journal of pharmaceutics | 2006 | 501 | 1 | |||
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides) | International journal of pharmaceutics | 2006 | 513 | 4 | |||
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: An EPR imaging study | Journal of controlled release | 2006 | 130 | 0 | |||
An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical Administration | Drugs in R&D | 2006 | 71 | 52 | |||
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH | International journal of pharmaceutics | 2006 | 476 | 1 | |||
Intraocular implants for extended drug delivery: therapeutic applications | Advanced drug delivery reviews | 2006 | 525 | 1 | |||
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates | European journal of pharmaceutics and biopharmaceutics | 2006 | 344 | 1 | |||
Biodegradable scleral implants as new triamcinolone acetonide delivery systems | International journal of pharmaceutics | 2006 | 431 | 1 | |||
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives | Photochemistry and photobiology | 2006 | 58 | 0 | |||
In vitro and in vivo activities of verteporfin-loaded nanoparticles | Journal of Controlled Release | 2005 | 123 | 0 | |||
Coupling Methods to Obtain Ligand-Targeted Liposomes and Nanoparticles | Microencapsulation : methods and industrial applications | 2005 | 34 | 0 | |||
Conversion of cyclosporine A prodrugs in human tears vs rabbits tears | European journal of pharmaceutics and biopharmaceutics | 2005 | 407 | 0 | |||
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye | Chimia | 2005 | 405 | 0 | |||
A water-soluble prodrug of cyclosporine A for ocular application: A stability study | European journal of pharmaceutical sciences | 2005 | 711 | 561 | |||
Trans-scleral diffusion of triamcinolone acetonide | Current eye research | 2005 | 469 | 1 | |||
The use of drug-loaded nanoparticles in cancer chemotherapy | Microencapsulation : Methods and Industrial Applications | 2005 | 31 | 0 | |||
Pseudo-thermosetting chitosan hydrogels for biomedical application | International journal of pharmaceutics | 2005 | 467 | 1 | |||
Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in Geneva | Chimia | 2005 | 366 | 0 | |||
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics | International journal of pharmaceutics | 2005 | 495 | 1 | |||
Synthesis and Ring-Opening Polymerization of New Monoalkyl-Substituted Lactides | Journal of polymer science. Part A, Polymer chemistry | 2004 | 177 | 0 | |||
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos | International journal of pharmaceutics | 2004 | 453 | 1 | |||
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance | European journal of pharmaceutics and biopharmaceutics | 2004 | 453 | 0 | |||
New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance | European journal of pharmaceutics and biopharmaceutics | 2004 | 449 | 3 | |||
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications | European journal of pharmaceutics and biopharmaceutics | 2004 | 487 | 1 | |||
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting | European journal of pharmaceutics and biopharmaceutics | 2004 | 382 | 4 | |||
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications | European journal of pharmaceutics and biopharmaceutics | 2004 | 414 | 1 | |||
Current Methods for Attaching Targeting Ligands to Liposomes and Nanoparticles | Journal of Pharmaceutical Sciences | 2004 | 121 | 0 | |||
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation | Journal of biomedical materials research. Part A | 2003 | 106 | 0 | |||
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles | Investigative Ophthalmology & Visual Science | 2003 | 409 | 96 | |||
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy | European journal of pharmaceutics and biopharmaceutics | 2003 | 605 | 0 | |||
Bioadhesive Ophthalmic Drug Inserts (BODI) | Modified-release drug delivery technology | 2003 | 62 | 60 | |||
In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance Imaging | Macromolecules | 2003 | 679 | 0 | |||
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologies | European journal of pharmaceutics and biopharmaceutics | 2003 | 407 | 1 | |||
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity | Photochemistry and photobiology | 2003 | 36 | 0 | |||
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans | AAPS PharmSci | 2002 | 510 | 0 | |||
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery | Journal of controlled release | 2002 | 456 | 0 | |||
Ocular tolerance of absorption enhancers in ophthalmic preparations | AAPS PharmSci | 2002 | 403 | 1 | |||
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles | International journal of pharmaceutics | 2002 | 424 | 2 | |||
State of the art in the delivery of photosensitizers for photodynamic therapy | Journal of photochemistry and photobiology. B, Biology | 2002 | 37 | 0 | |||
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye | Investigative ophthalmology and visual science | 2002 | 159 | 75 | |||
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle | AAPS PharmSci | 2001 | 449 | 0 | |||
Therapeutic applications of viscous and injectable poly(ortho esters) | Advanced drug delivery reviews | 2001 | 465 | 1 | |||
Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles | Pharmaceutical research | 2001 | 24 | 35 | |||
Fluorescence correlation spectroscopy for the characterisation of drug delivery systems | Biological chemistry | 2001 | 459 | 0 | |||
Challenges of Intraocular Drug Delivery | European pharmaceutical review | 2001 | 66 | 6 | |||
Influence of hot-melt extrusion and compression molding on polymer structure organization, investigated by differential scanning calorimetry | Journal of Applied Polymer Science | 2001 | 308 | 0 | |||
Release of BSA from poly(ortho ester) extruded thin strands | Journal of Controlled Release | 2001 | 184 | 0 | |||
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery | Investigative Ophthalmology & Visual Science | 2001 | 232 | 82 | |||
Treatment of Intralocular Diseases with Poly(ortho ester)-Based Drug Delivery Systems | Macromolecular symposia | 2001 | 60 | 0 | |||
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs | AAPS PharmSci | 2001 | 496 | 0 | |||
Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation | International journal of pharmaceutics | 2001 | 421 | 1 | |||
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket | Biomaterials | 2001 | 426 | 1 | |||
Protein Release from Poly(ortho ester) Extruded Rods | Macromolecular symposia | 2001 | 43 | 0 | |||
Development of poly(ortho esters) | Drug delivery systems & sciences | 2001 | 359 | 1 | |||
Polymeric systems for ophthalmic drug delivery | Polymeric Biomaterials | 2001 | 30 | 0 | |||
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles | International journal of pharmaceutics | 2001 | 492 | 1 | |||
Poly(ortho esters) - A Versatile Drug Delivery System | Biomaterials and Drug Delivery toward New Mellenium | 2000 | 392 | 0 | |||
Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle Technology | Pharmaceutical research | 2000 | 27 | 36 | |||
Poly (ortho esters) implants for the sustained delivery of a protein factors influencing the release behaviour of BSA in vitro | The 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference | 2000 | 22 | 6 | |||
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state | Journal of controlled release | 2000 | 134 | 0 | |||
Poly(ortho esters) - their development and some recent applications | European journal of pharmaceutics and biopharmaceutics | 2000 | 466 | 1 | |||
Local delivery of antimicrobial agents for the treatment of periodontal diseases | European journal of pharmaceutics and biopharmaceutics | 2000 | 381 | 1 | |||
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation | Biomaterials | 2000 | 509 | 2 | |||
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release | European journal of pharmaceutics and biopharmaceutics | 2000 | 562 | 0 | |||
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants | International journal of pharmaceutics | 2000 | 419 | 1 | |||
A novel analytical approach for the characterization of poly(MePegcyanoacrylate - co - hexadecylcyanoacrylate) nanoparticles | The 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference | 2000 | 21 | 15 | |||
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles | Pharmaceutical development and technology | 2000 | 30 | 0 | |||
Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial Efficacy | Journal of Ocular Pharmacology and Therapeutics | 2000 | 87 | 0 | |||
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses | European journal of pharmaceutics and biopharmaceutics | 2000 | 443 | 1 | |||
Formation of peptide impurities in polyester matrices during implant manufacturing | European journal of pharmaceutics and biopharmaceutics | 2000 | 539 | 0 | |||
Formulation and technology aspects of conrolled drug delivery in animals | Pharmaceutical science & technology today | 2000 | 42 | 0 | |||
Design and development of controlled release veterinary drug delivery systems to the eye | Controlled Release Veterinary Drug Delivery | 2000 | 103 | 0 | |||
Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimization | CRS proceedings | 1999 | 26 | 6 | |||
Production of biodegradable implants for the sustained release of pharmaceuticals | Asian Conference and Exhibition of Controlled Release | 1999 | 394 | 1 | |||
Evaluation of the local and systemic inflammatory responses induced by the subcutaneous injection of different biopolymers | CRS proceedings | 1999 | 19 | 9 | |||
Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymers | CRS proceedings | 1999 | 27 | 5 | |||
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention | International journal of pharmaceutics | 1999 | 467 | 1 | |||
Hydrolysis and Erosion Studies of Autocatalyzed Poly(ortho esters) Containing Lactoyl−Lactyl Acid Dimers | Macromolecules | 1999 | 77 | 0 | |||
How to avoid the formation of peptide impurities during manufacturing of implants by melt-extrusion ? | CRS proceedings | 1999 | 22 | 5 | |||
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application | Journal of biomedical materials research | 1999 | 103 | 63 | |||
Erosion, properties and drug release from a new family of poly(ortho esters) | Proceedings of the 26th International Symposium on Controlled Release of Bioactive Materials and the Second Conference on Consumer and Diversified Products | 1999 | 21 | 6 | |||
Poly(ortho esters) | Encyclopedia of controlled drug delivery | 1999 | 76 | 0 | |||
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake | Pharmaceutical research | 1999 | 23 | 41 | |||
Biodegradable implants | Asian Conference and Exhibition of Controlled Release | 1999 | 354 | 35 | |||
Evaluation of poly(ortho ester) for intraocular application in rabbits: biocompatibility assessment and in vitro degradation | CRS proceedings | 1999 | 20 | 46 | |||
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex | European journal of pharmaceutical sciences | 1999 | 460 | 0 | |||
Poly(ortho ester): a new biocompatible intraocular drug delivery system | Asian Conference and Exhibition of Controlled Release | 1999 | 53 | 10 | |||
Ocular tolerance of preservatives on the murine cornea | European journal of pharmaceutics and biopharmaceutics | 1999 | 371 | 1 | |||
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate | Journal of biomaterials science. Polymer ed | 1999 | 104 | 0 | |||
Stability studies of a somatostatin analogue in biodegradable implants | International journal of pharmaceutics | 1999 | 405 | 1 | |||
Mucosal drug delivery, ocular | Encyclopedia of controlled drug delivery | 1999 | 99 | 0 | |||
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants | European journal of pharmaceutics and biopharmaceutics | 1999 | 479 | 3 | |||
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization | European journal of pharmaceutics and biopharmaceutics | 1999 | 422 | 2 | |||
Mucosal drug delivery, intravitreal | Encyclopedia of controlled drug delivery | 1999 | 101 | 0 | |||
Gamma scintigraphy as tool for the evaluation of precorneal residence time: influence of the methodology | CRS proceedings | 1999 | 20 | 5 | |||
Nanoparticles | Encyclopedia of controlled drug delivery | 1999 | 120 | 0 | |||
Protein delivery from extruded poly(ortho esters) | Asian Conference and Exhibition of Controlled Release | 1999 | 363 | 41 | |||
Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systems | CRS proceedings | 1999 | 23 | 25 | |||
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester) | International journal of pharmaceutics | 1999 | 537 | 0 | |||
Synthesis and characterization of self-catalyzed poly(ortho ester) | Biomaterials | 1998 | 587 | 0 | |||
Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 475 | 2 | |||
Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 280 | 1 | |||
pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 456 | 1 | |||
In vitro drug release from self-catalyzed poly(ortho ester): Case study of 5-fluorouracil | Journal of controlled release | 1998 | 131 | 0 | |||
Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 585 | 1 | |||
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries | European journal of pharmaceutics and biopharmaceutics | 1998 | 438 | 1 | |||
Biodegradable polymers for the controlled release of ocular drugs | Progress in polymer science | 1998 | 28 | 0 | |||
Chitosan: a unique polysaccharide for drug delivery | Drug development and industrial pharmacy | 1998 | 481 | 0 | |||
A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 412 | 1 | |||
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections | Journal of controlled release | 1998 | 582 | 0 | |||
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 392 | 1 | |||
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue | Journal of controlled release | 1998 | 158 | 0 | |||
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics | Advanced drug delivery reviews | 1998 | 389 | 0 | |||
Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells | 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 1998 | 420 | 1 | |||
Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular Tolerance | Journal of Ocular Pharmacology and Therapeutics | 1998 | 69 | 0 | |||
Bioerodible Polymers for Ocular Drug Delivery | Critical reviews in therapeutic drug carrier systems | 1998 | 109 | 0 | |||
Influence of irradiation sterilization on a semi-solid poly(ortho ester) | International journal of pharmaceutics | 1998 | 473 | 0 | |||
Therapeutic applications of retinoids in ophthalmology | International journal of pharmaceutics | 1997 | 407 | 2 | |||
Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug release | International journal of pharmaceutics | 1997 | 463 | 1 | |||
Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue | European journal of pharmaceutical sciences | 1997 | 434 | 0 | |||
Prophylaxis of caries : in vivo evaluation of various oral fluoride containing preparations designed to optimize salivary concentrations | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 27 | 0 | |||
Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A Review | Drug development and industrial pharmacy | 1997 | 511 | 1 | |||
Determination of dexamethasone in tears by capillary electrophoresis | Journal of chromatography. B, Biomedical sciences and applications | 1997 | 474 | 0 | |||
Confocal Microscopy as a Tool for the Investigation of the Anterior Part of the Eye | Journal of Ocular Pharmacology and Therapeutics | 1997 | 65 | 0 | |||
Ocular drug delivery in veterinary medicine | Advanced drug delivery reviews | 1997 | 490 | 0 | |||
PLA-PEG nanoparticles: preparation and cell interaction studies | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 21 | 5 | |||
In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral use | European journal of pharmaceutics and biopharmaceutics | 1997 | 377 | 1 | |||
Synthesis and characterization of ointment-like self-catalyzed poly(ortho ester) | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 21 | 37 | |||
New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibility | Journal of controlled release | 1997 | 200 | 0 | |||
Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axis | European journal of pharmaceutics and biopharmaceutics | 1997 | 137 | 0 | |||
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations | Pharmaceutica Acta Helvetiae | 1997 | 22 | 0 | |||
Combined release of dexamethasone and gentamicin from an ocular insert for treatment of external ophthalmic infections | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 37 | 10 | |||
Development of a long-term delivery system for RC-160, a somatostatin analog | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 20 | 2 | |||
Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localization | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 50 | 25 | |||
Improved biocompatibility of a viscous bioerodable poly(orthoester) by controlling the environmental pH | Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials | 1997 | 17 | 42 | |||
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement | Journal of biomedical materials research | 1997 | 80 | 0 | |||
Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticles | Acta pharmaceutica | 1996 | 361 | 97 | |||
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs | Pharmaceutical research | 1996 | 21 | 18 | |||
Basis for Dosing Time-Dependent Changes in the Ocular and Systemic Absorption of Topically Applied Timolol | Journal of Ocular Pharmacology and Therapeutics | 1996 | 82 | 0 | |||
Development of a Novel Soluble Ophthalmic Insert: Evaluation of Ocular Tolerance in Rabbits | European journal of pharmaceutics and biopharmaceutics | 1996 | 136 | 34 | |||
Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy Volunteers | Journal of Ocular Pharmacology and Therapeutics | 1996 | 65 | 0 | |||
Biomaterials in Ophthalmic Drug Delivery | European journal of pharmaceutics and biopharmaceutics | 1996 | 325 | 62 | |||
The Use of Drug-Loaded Nanoparticles in Cancer Chemotherapy | Microencapsulation : methods and industrial applications | 1996 | 22 | 0 | |||
Mucoadhesive Semi-Solid Formulations for Intraoral Use Containing Sucralfate | European journal of pharmaceutics and biopharmaceutics | 1996 | 196 | 144 | |||
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery | Journal of controlled release | 1996 | 40 | 0 | |||
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems | Biomaterials | 1996 | 467 | 2 | |||
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert | Pharmaceutical research | 1995 | 24 | 30 | |||
Patent Literature Review of Ophthalmic Inserts | Drug development and industrial pharmacy | 1995 | 480 | 2 | |||
The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester) | Journal of controlled release | 1995 | 29 | 0 | |||
Use of Insoluble Biodegradable Polymers in Ophthalmic Systems for the Sustained Release of Drugs | European journal of pharmaceutics and biopharmaceutics | 1995 | 147 | 116 | |||
Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation | Journal of controlled release | 1995 | 28 | 0 | |||
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels | Advanced drug delivery reviews | 1995 | 520 | 0 | |||
New Approach for the Preparation of Nanoparticles by an Emulsification-Diffusion Method | European journal of pharmaceutics and biopharmaceutics | 1995 | 498 | 930 | |||
PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary Tumours | Journal of Pharmacy and Pharmacology | 1995 | 116 | 0 | |||
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes | Life sciences | 1995 | 93 | 1 | |||
Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice | Journal of Pharmaceutical Sciences | 1995 | 69 | 0 | |||
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery: validation and radiation effects | Pharmaceutical research | 1994 | 26 | 17 | |||
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymers | Journal of biomaterials science. Polymer ed | 1994 | 133 | 0 | |||
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil | Journal of biomedical materials research | 1994 | 105 | 0 | |||
Application of Medical Imaging to Pharmaceutical Research: the Example of Gamma Scintigraphy. I: Technological Aspects | European journal of pharmaceutics and biopharmaceutics | 1994 | 131 | 12 | |||
Long-term histopathological study of new polypeptidic biomaterials | Biomaterials | 1992 | 493 | 2 | |||
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size | International journal of pharmaceutics | 1992 | 572 | 2 | |||
Aqueous nanodispersions prepared by a salting-out process | International journal of pharmaceutics | 1992 | 526 | 1 |